Literature DB >> 12040207

Mandibular ameloblastoma: analysis of surgical treatment carried out in 60 patients between 1977 and 1998.

R Becelli1, A Carboni, G Cerulli, Maurizio Perugini, G Iannetti.   

Abstract

Ameloblastoma, a benign tumor of odontogenic type, represents 10% of all tumors of the jawbone. It is localized in the mandible in 80% of cases and in the upper jaw in the remaining 20%. In every case, the selection of the surgical treatment to be applied must consider some fundamental elements, including the age and general state of health of the patient, the clinicopathological variant, and the localization and extent of the tumor. In addition, it is necessary to evaluate whether the neoplasm to be treated is a primitive lesion or a recurrence. Although ameloblastoma has relative histological characteristics of benignity, this neoplasm has a high percentage of local recurrence and possible malignant development when treated inadequately. The aim of this study was to carry out a follow-up of 60 patients treated for ameloblastoma of the mandible between 1977 and 1998, analyzing the problems faced in removing this benign neoplasm and those concerning reconstruction of the surgical defect.

Entities:  

Mesh:

Year:  2002        PMID: 12040207     DOI: 10.1097/00001665-200205000-00006

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  25 in total

1.  Ameloblastoma: 25 Year Experience at a Single Institution.

Authors:  Tatyana Milman; Gui-Shuang Ying; Wei Pan; Virginia LiVolsi
Journal:  Head Neck Pathol       Date:  2016-06-07

2.  Is conservative surgery a better choice for the solid/multicystic ameloblastoma than radical surgery regarding recurrence? A systematic review.

Authors:  Yuri Slusarenko da Silva; Natalia Aguiar Tartaroti; Daniel Isaac Sendyk; Maria Cristina Zindel Deboni; Maria da Graça Naclério-Homem
Journal:  Oral Maxillofac Surg       Date:  2018-09-06

3.  Prosthetic rehabilitation of patient with ameloblastoma: a case report.

Authors:  N Kalavathy; K Premnath; N Jayanthi; Vijetha Jadav
Journal:  J Indian Prosthodont Soc       Date:  2011-06-21

4.  Ameloblastoma: an aggressive lesion of the mandible.

Authors:  M S Suma; K J Sundaresh; R Shruthy; Rachappa Mallikarjuna
Journal:  BMJ Case Rep       Date:  2013-10-09

5.  Recombinant human bone morphogenetic protein-2 (rhBMP-2) in the treatment of mandibular sequelae after tumor resection.

Authors:  André Zétola; Felipe Mussi Ferreira; Rafaela Larson; Jamil Awad Shibli
Journal:  Oral Maxillofac Surg       Date:  2010-06-24

Review 6.  Ameloblastoma: a clinical review and trends in management.

Authors:  Andrew C McClary; Robert B West; Ashley C McClary; Jonathan R Pollack; Nancy J Fischbein; Christopher F Holsinger; John Sunwoo; A Dimitrios Colevas; Davud Sirjani
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-30       Impact factor: 2.503

Review 7.  Ameloblastoma, a rare benign odontogenic tumour: an interesting tumour review targeting the role of radiation therapy.

Authors:  G V Koukourakis; A Miliadou; A Sotiropoulou-Lontou
Journal:  Clin Transl Oncol       Date:  2011-11       Impact factor: 3.405

8.  Treatment of ameloblastoma and ameloblastic carcinoma with radiotherapy.

Authors:  William R Kennedy; John W Werning; Frederic J Kaye; William M Mendenhall
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-21       Impact factor: 2.503

9.  A repeatedly recurrent desmoplastic ameloblastoma after removal and allobone graft: Radiographic features compared with histological changes.

Authors:  Jae-Duk Kim; Hyun-Seon Jang; Yo-Seob Seo; Jin-Soo Kim
Journal:  Imaging Sci Dent       Date:  2013-09-23

10.  Iliac crest bone grafting for mandibular reconstruction: 10-year experience outcomes.

Authors:  Timothy M Osborn; Deeb Helal; Pushkar Mehra
Journal:  J Oral Biol Craniofac Res       Date:  2017-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.